SHALINI MAKAWITA to Molecular Targeted Therapy
This is a "connection" page, showing publications SHALINI MAKAWITA has written about Molecular Targeted Therapy.
Connection Strength
0.175
-
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial. Future Oncol. 2020 Oct; 16(30):2375-2384.
Score: 0.141
-
Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait. BMC Cancer. 2019 Oct 17; 19(1):965.
Score: 0.034